Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twir...
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report fourth quarter and full
year 2020 financial results after the market close on Monday, March
1, 2021. Following the release, the Company will host a live
conference call and webcast at 4:30 p.m. ET to discuss the
Company’s financial results and provide a business update.
Investors and other interested parties may participate by
registering for a teleconference line or live webcast link in the
Events and Presentations section of the Investor Relations page at
https://ir.agiletherapeutics.com/events-and-presentations, or by
Please log in approximately 10 minutes prior to the scheduled
start time. The archived webcast will be available in the Events
and Presentations section of the company's website.
About Agile Therapeutics, Inc.Agile Therapeutics is a women's
healthcare company dedicated to fulfilling the unmet health needs
of today’s women. Our product candidates are designed to provide
women with contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The Company may occasionally
disseminate material, nonpublic information on the Company’s
Follow Agile on LinkedIn and Twitter: @AgileTher.
Contact: Matt RileyHead of Investor Relations & Corporate